- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Cholangiocarcinoma in New Zealand
Total 116 results
-
Rutgers, The State University of New JerseyRecruitingIntrahepatic Cholangiocarcinoma | Cholangiocarcinoma, IntrahepaticUnited States
-
National Cancer Institute (NCI)CompletedStage III Intrahepatic Cholangiocarcinoma AJCC v8 | Gallbladder Carcinoma | Metastatic Cholangiocarcinoma | Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 | Unresectable CholangiocarcinomaUnited States
-
Yale UniversityTerminatedUnresectable Intrahepatic CholangiocarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterWashington University School of Medicine; Ohio State University; University of...CompletedIntrahepatic Cholangiocarcinoma | Peripheral Cholangiocarcinoma | Cholangiolar Carcinoma | Cholangiocellular Carcinoma) (ICC)United States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingIntrahepatic Cholangiocarcinoma | Cholangiocellular Carcinoma | Peripheral Cholangiocarcinoma | Cholangiolar CarcinomaUnited States
-
NRG OncologyNational Cancer Institute (NCI)TerminatedStage III Intrahepatic Cholangiocarcinoma | Stage IVA Intrahepatic CholangiocarcinomaUnited States, Canada
-
National Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Cholangiocarcinoma | Stage III Intrahepatic Cholangiocarcinoma AJCC v8 | Gallbladder Carcinoma | Stage III Gallbladder Cancer AJCC v8 | Stage III Hilar Cholangiocarcinoma AJCC v8 | Stage IV Gallbladder Cancer AJCC v8 | Stage IV Hilar Cholangiocarcinoma AJCC v8 | Stage IV Intrahepatic...United States
-
Halozyme TherapeuticsTerminatedCholangiocarcinoma Non-resectable | Cholangiocarcinoma, Extrahepatic | Cholangiocarcinoma, Intrahepatic | Gallbladder AdenocarcinomaUnited States, Korea, Republic of, Thailand
-
Memorial Sloan Kettering Cancer CenterRecruitingIntrahepatic CholangiocarcinomaUnited States
-
Incyte CorporationRecruitingMetastatic Cholangiocarcinoma | Unresectable CholangiocarcinomaUnited States, Canada, Belgium, France, Germany, Italy, China, Spain, Japan, United Kingdom, Netherlands, Switzerland, Austria, Denmark, Finland, Ireland, Israel, Norway, Sweden
-
Weill Medical College of Cornell UniversityUnknownBiliary Stricture | Unresectable Cholangiocarcinoma | Biliary Obstruction | Stent ObstructionUnited States
-
Institut de Recherches Internationales ServierCompletedMetastatic Cholangiocarcinoma | Advanced CholangiocarcinomaUnited States, Spain, Korea, Republic of, Italy, France, United Kingdom
-
Servier Bio-Innovation LLCInstitut de Recherches Internationales ServierRecruitingIDH1-mutant CholangiocarcinomaUnited States, United Kingdom
-
Sirtex MedicalCompletedIntrahepatic CholangiocarcinomaFrance, United Kingdom, Belgium, Australia, Spain, United States, Italy, Netherlands
-
Concordia Laboratories Inc.TerminatedHilar CholangiocarcinomaUnited States, Korea, Republic of, Canada, Switzerland, Germany
-
National Cancer Institute (NCI)Active, not recruitingStage III Intrahepatic Cholangiocarcinoma AJCC v8 | Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8 | Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8 | Unresectable Hepatocellular Carcinoma | Metastatic Cholangiocarcinoma | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IIIA Hepatocellular... and other conditionsUnited States
-
Basilea PharmaceuticaArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...CompletedSolid TumorUnited States, Italy
-
University of New MexicoTerminatedCholangiocarcinomaUnited States
-
National Cancer Institute (NCI)SuspendedMalignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Refractory CholangiocarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
TriSalus Life Sciences, Inc.Active, not recruitingHepatocellular Carcinoma | Intrahepatic CholangiocarcinomaUnited States
-
Roswell Park Cancer InstituteGenentech, Inc.CompletedCholangiocarcinomaUnited States
-
Weill Medical College of Cornell UniversityTerminatedCholangiocarcinoma Non-resectable | Unresectable Pancreatic CancerUnited States
-
PrECOG, LLC.Celgene CorporationCompletedCholangiocarcinomaUnited States, Austria
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedFGFR2 Gene Mutation | Advanced CholangiocarcinomaKorea, Republic of, United States, Belgium, Spain, Taiwan, China, United Kingdom, France, Canada, Germany, Thailand, Italy, Portugal, Australia, Puerto Rico
-
Genoscience PharmaTerminatedHepatocellular Carcinoma | Cholangiocarcinoma, IntrahepaticFrance, United States, Belgium
-
Kinnate BiopharmaActive, not recruitingIntrahepatic Cholangiocarcinoma | Urothelial Carcinoma | Solid Tumor, AdultUnited States, Korea, Republic of, Taiwan, China, Denmark, Spain
-
Basilea PharmaceuticaCompletedIntrahepatic Cholangiocarcinoma | Combined Hepatocellular and CholangiocarcinomaCanada, United States, Spain, Belgium, Italy, Korea, Republic of, Germany, Switzerland, France, United Kingdom, Ireland
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedFGFR2 Gene Mutation | Advanced CholangiocarcinomaUnited States, Belgium, Germany, Italy, Korea, Republic of, Russian Federation, Singapore, Spain, Taiwan, Thailand, United Kingdom
-
Taiho Oncology, Inc.Active, not recruitingAdvanced Cholangiocarcinoma | FGFR2 Gene RearrangementsUnited States, Spain, United Kingdom, Australia, Taiwan, Italy, France, Korea, Republic of, Belgium, Japan, Thailand, Germany, Brazil, Peru, Portugal, Argentina, Hong Kong, Mexico, Netherlands, Poland
-
National Cancer Institute (NCI)RecruitingStage III Intrahepatic Cholangiocarcinoma AJCC v8 | Recurrent Gallbladder Carcinoma | Unresectable Gallbladder Carcinoma | Stage III Hilar Cholangiocarcinoma AJCC v8 | Stage IV Hilar Cholangiocarcinoma AJCC v8 | Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 | Stage IV Distal Bile Duct Cancer... and other conditionsUnited States
-
Weill Medical College of Cornell UniversityWithdrawnCholangiocarcinomaUnited States
-
Forma Therapeutics, Inc.CompletedCohort 1a and 1b: Glioma (Advanced Gliomas and Glioblastoma Multiforme) | Cohort 2a and 2b: Hepatobiliary Tumors (Hepatocellular Carcinoma, Bile Duct Carcinoma, Intrahepatic Cholangiocarcinoma, Other Hepatobiliary Carcinomas) | Cohort 3a and 3b: Chondrosarcoma | Cohort 4a and 4b: Intrahepatic... and other conditionsUnited States, Korea, Republic of, Australia, United Kingdom, Spain, France
-
Heinrich-Heine University, DuesseldorfServierCompleted
-
GenfitRecruitingCholangiocarcinomaUnited States, Puerto Rico
-
TransThera Sciences (Nanjing), Inc.AvailableAdvanced Solid Tumors | CholangiocarcinomaUnited States
-
Criterium, Inc.University of Colorado, Denver; NovartisTerminatedPancreatic Adenocarcinoma | Gastric Adenocarcinoma | Cholangiocarcinoma | Esophageal Adenocarcinoma | Colorectal Adenocarcinoma | Hepatocellular AdenocarcinomaUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingStage III Intrahepatic Cholangiocarcinoma AJCC v8 | Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8 | Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8 | Stage III Gallbladder Cancer AJCC v8 | Stage IIIA Gallbladder Cancer AJCC v8 | Stage IIIB Gallbladder Cancer AJCC v8 | Unresectable Extrahepatic... and other conditionsUnited States
-
Beijing InnoCare Pharma Tech Co., Ltd.RecruitingAdvanced Solid Tumors | Cholangiocarcinoma | Urothelial CarcinomaAustralia, United States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Gallbladder Carcinoma | Metastatic Gallbladder Carcinoma | Stage IV Gallbladder Cancer AJCC v8 | Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 | Stage IV Distal Bile Duct Cancer AJCC v8 | Metastatic Intrahepatic Cholangiocarcinoma | Recurrent Intrahepatic Cholangiocarcinoma | Metastatic... and other conditionsUnited States
-
New Mexico Cancer Care AllianceTerminatedHepatocellular Carcinoma | Bile Duct Cancer | Gallbladder Cancer | Cholangiocellular Carcinoma | Extrahepatic Bile Duct Cancer | Cholangiocarcinoma of the Extrahepatic Bile Duct | Periampullary AdenocarcinomaUnited States
-
Mauna Kea TechnologiesCompletedCholangiocarcinoma | Bile Duct InflammationUnited States, France, Italy
-
National Cancer Institute (NCI)Active, not recruitingGlioblastoma | WHO Grade 3 Glioma | Advanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Glioma | Recurrent Cholangiocarcinoma | WHO Grade 2 GliomaUnited States
-
Relay Therapeutics, Inc.Active, not recruitingCholangiocarcinoma | Intrahepatic Cholangiocarcinoma | FGFR2 Gene Mutation | FGFR2 Amplification | FGFR2 Gene Fusion/Rearrangement | FGFR2 Gene Translocation | FGFR2 Gene Activation | Other Solid Tumors, AdultUnited States, France, Italy, United Kingdom, Korea, Republic of, Spain, Taiwan, Sweden, Germany, Netherlands, Singapore, Australia, Hong Kong
-
Incyte CorporationCompletedCholangiocarcinomaUnited States, France, Italy, United Kingdom, Germany, Taiwan, Spain, Belgium, Israel, Korea, Republic of, Japan, Thailand
-
Hackensack Meridian HealthCompletedPancreatic Cancer | Lung Cancer | Cholangiocarcinoma | Liver CancerUnited States
-
TransThera Sciences (Nanjing), Inc.RecruitingCholangiocarcinomaKorea, Republic of, United States, Taiwan, Spain, France, Belgium, Germany, Italy, Portugal, United Kingdom, Austria, Poland
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingColorectal Cancer | CholangiocarcinomaUnited States
-
Weill Medical College of Cornell UniversityEMcision LimitedTerminatedPancreatic Cancer | CholangiocarcinomaUnited States
-
TransThera Sciences (Nanjing), Inc.CompletedCholangiocarcinoma | FGFR2 Gene Mutation | FGFR2 Fusion | FGFR1 Alteration | FGFR3 AlterationUnited States